The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

Mon, 19 Oct 2026 08:30:00 -0400

AUSTIN, Texas, Oct. 19, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: American healthcare is moving from treating illness after it strikes to preventing it before it starts. U.S. health spending reached $5.3 trillion in 2024, and Medicare Advantage now covers 35.2 million people, or 55% of eligible beneficiaries. KFF projects Medicare Advantage payments of $574 billion in 2026, giving health plans a powerful reason to keep members healthy. That shift is opening the door for a new kind of player. ECGI Holdings Inc. (OTC: ECGI) (

The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

Mon, 19 Oct 2026 08:30:00 -0400

The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

Mon, 19 Oct 2026 08:30:00 -0400

The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

Mon, 19 Oct 2026 08:30:00 -0400

The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

Mon, 19 Oct 2026 08:30:00 -0400

The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

Mon, 19 Oct 2026 08:30:00 -0400

The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

Mon, 19 Oct 2026 08:30:00 -0400

The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

Mon, 19 Oct 2026 08:30:00 -0400

Vaxart adds retired vice admiral and surgeon to its board

Mon, 19 Oct 2026 08:01:08 -0400

Vaxart, Inc. (OTCQB: VXRT) has appointed Raquel "Rocky" C. Bono, M.D., a retired U.S. Navy Vice Admiral, to its board of directors, according to a company statement.

Dr. Bono's appointment follows a cooperation agreement Vaxart entered into with a group of its stockholders in July 2026. She will serve as Chair of the Stockholder Engagement Committee and as a member of the Nominating and Governance Committee and the Clinical and Regulatory Affairs Committee.

Dr. Bono is a board-certified trauma surgeon who previously served as Director of the Defense Health Agency, where she oversaw a $50 billion integrated global healthcare system serving 9.5

Vaxart adds retired vice admiral and surgeon to its board

Mon, 19 Oct 2026 08:01:08 -0400

Vaxart, Inc. (OTCQB: VXRT) has appointed Raquel "Rocky" C. Bono, M.D., a retired U.S. Navy Vice Admiral, to its board of directors, according to a company statement.

Dr. Bono is a board-certified trauma surgeon who previously served as Director of the Defense Health Agency, where she oversaw a $50 billion integrated global healthcare system serving 9.5

Vaxart adds retired vice admiral and surgeon to its board

Mon, 19 Oct 2026 08:01:08 -0400

Vaxart, Inc. (OTCQB: VXRT) has appointed Raquel "Rocky" C. Bono, M.D., a retired U.S. Navy Vice Admiral, to its board of directors, according to a company statement.

Dr. Bono is a board-certified trauma surgeon who previously served as Director of the Defense Health Agency, where she oversaw a $50 billion integrated global healthcare system serving 9.5

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

Mon, 19 Oct 2026 08:00:00 -0400

Board-certified surgeon and former Director of the Defense Health Agency brings extensive leadership, public health and governance experience

SOUTH SAN FRANCISCO, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQB: VXRT) (the “Company” or “Vaxart”), a clinical-stage biotechnology company developing a portfolio of oral recombinant vaccines based on its proprietary delivery platform, today announced the appointment of Raquel “Rocky” C. Bono, M.D., Vice Admiral, U.S. Navy (Ret.), to its Board of Directors.

Dr. Bono was appointed pursuant to the cooperation agreement Vaxart entered into with a group of its stockholders in July 2026. She

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

Mon, 19 Oct 2026 08:00:00 -0400

Board-certified surgeon and former Director of the Defense Health Agency brings extensive leadership, public health and governance experience

Dr. Bono was appointed pursuant to the cooperation agreement Vaxart entered into with a group of its stockholders in July 2026. She

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

Mon, 19 Oct 2026 08:00:00 -0400

Board-certified surgeon and former Director of the Defense Health Agency brings extensive leadership, public health and governance experience

Dr. Bono was appointed pursuant to the cooperation agreement Vaxart entered into with a group of its stockholders in July 2026. She

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

Mon, 19 Oct 2026 08:00:00 -0400

Board-certified surgeon and former Director of the Defense Health Agency brings extensive leadership, public health and governance experience

Dr. Bono was appointed pursuant to the cooperation agreement Vaxart entered into with a group of its stockholders in July 2026. She

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

Mon, 19 Oct 2026 08:00:00 -0400

Board-certified surgeon and former Director of the Defense Health Agency brings extensive leadership, public health and governance experience

Dr. Bono was appointed pursuant to the cooperation agreement Vaxart entered into with a group of its stockholders in July 2026. She

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

Mon, 19 Oct 2026 08:00:00 -0400

Board-certified surgeon and former Director of the Defense Health Agency brings extensive leadership, public health and governance experience

Dr. Bono was appointed pursuant to the cooperation agreement Vaxart entered into with a group of its stockholders in July 2026. She

Humana (HUM) PT Raised to $495 at Mizuho

Tue, 13 Oct 2026 06:36:01 -0400

Mizuho analyst Ann Hynes raised the price target on Humana (NYSE: HUM) to $495.00 (from $468.00) while maintaining a Outperform rating.

Humana forms joint venture with BlackRock for CenterWell clinics

Tue, 13 Oct 2026 06:22:15 -0400

Humana Inc. (NYSE: HUM) has entered into a joint venture agreement with funds managed by HPS Investment Partners, a part of BlackRock, to manage and operate a network of nearly 150 CenterWell Senior Primary Care clinics, replacing existing joint ventures with Welsh, Carson, Anderson & Stowe (WCAS).

Under the agreement, BlackRock will acquire WCAS's current equity stake, valued at approximately $2.8 billion. The new joint venture will be majority owned by BlackRock and minority owned by CenterWell, with CenterWell continuing to manage operations at all clinics.

Over the next two years, the joint venture is expected to deploy additional capital to fund

Humana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics

Tue, 13 Oct 2026 06:22:00 -0400

The new joint venture arrangement will replace CenterWell’s existing joint ventures with Welsh, Carson, Anderson & Stowe (“WCAS”) through an acquisition of WCAS’s current equity stake by BlackRock.
CenterWell Senior Primary Care will continue to manage and operate all clinics owned through the joint venture.
Transaction is expected to provide Humana with enhanced balance sheet efficiency, additional growth capital, greater financial flexibility, and a reduced cost of capital.
Anticipated additional capital commitment for the joint venture can fuel future growth and reinforce CenterWell’s position as the nation’s largest senior-focused primary care provider.

LOUISVILLE, Ky.--(BUSINESS WIRE)--

Humana Inc. (NYSE: HUM)

Humana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics

Tue, 13 Oct 2026 06:22:00 -0400

The new joint venture arrangement will replace CenterWell’s existing joint ventures with Welsh, Carson, Anderson & Stowe (“WCAS”) through an acquisition of WCAS’s current equity stake by BlackRock.
CenterWell Senior Primary Care will continue to manage and operate all clinics owned through the joint venture.
Transaction is expected to provide Humana with enhanced balance sheet efficiency, additional growth capital, greater financial flexibility, and a reduced cost of capital.
Anticipated additional capital commitment for the joint venture can fuel future growth and reinforce CenterWell’s position as the nation’s largest senior-focused primary care provider.

LOUISVILLE, Ky.--(BUSINESS WIRE)--

Humana Inc. (NYSE: HUM)

Humana forms new clinic joint venture with BlackRock unit

Tue, 13 Oct 2026 06:09:32 -0400

Humana Inc. (NYSE: HUM) has entered into a new joint venture arrangement with funds and accounts managed by HPS Investment Partners, a subsidiary of BlackRock, Inc., to manage and operate a network of CenterWell Senior Primary Care clinics.

The new arrangement replaces CenterWell's existing joint ventures with funds affiliated with Welsh, Carson, Anderson & Stowe (WCAS), through BlackRock's acquisition of WCAS's current equity stake, with certain modifications to existing terms.

Unlike the prior arrangement, the new joint venture does not include a put option exercisable by BlackRock. Humana said it anticipates a significantly lower cost of capital under the new structure and

Humana forms new clinic joint venture with BlackRock unit

Tue, 13 Oct 2026 06:09:32 -0400

Form 8-K HUMANA INC For: Oct 13

Tue, 13 Oct 2026 06:05:00 -0400

si-local-file:///var/storage/secattach/20261013/27176333.html

Humana Inc. to Release Third Quarter 2026 Results on November 6, 2026

Mon, 12 Oct 2026 16:30:00 -0400

LOUISVILLE, Ky.--(BUSINESS WIRE)-- Humana Inc. (NYSE: HUM) will release its financial results for the third quarter 2026 (3Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on November 6, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026.

A webcast of the 3Q26 earnings call may be accessed via Humana’s Investor Relations page at https://humana.gcs-web.com/.

If you anticipate asking a question during the question-and-answer session, please register in advance

StreetInsider.com News Articles

The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

Vaxart adds retired vice admiral and surgeon to its board

Vaxart adds retired vice admiral and surgeon to its board

Vaxart adds retired vice admiral and surgeon to its board

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

Humana (HUM) PT Raised to $495 at Mizuho

Humana forms joint venture with BlackRock for CenterWell clinics

Humana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics

Humana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics

Humana forms new clinic joint venture with BlackRock unit

Humana forms new clinic joint venture with BlackRock unit

Form 8-K HUMANA INC For: Oct 13

Humana Inc. to Release Third Quarter 2026 Results on November 6, 2026